The government introduced RBI floating rate saving bonds for individual investors in 2020, replacing the 7.75% savings bonds.
The US Food and Drug Administration (FDA) has approved Omisirge (omidubicel-onlv), the first hematopoietic stem cell transplant (HSCT) therapy to treat patients with severe aplastic anaemia (SAA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback